NCT00249119View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia

PHASE3CompletedINTERVENTIONAL

Enrollment

1,579

Participants

Timeline

Start Date

Not specified

Study Completion Date

December 31, 1991

Conditions

SchizophreniaPsychotic Disorder

Interventions

DRUG

risperidone

All Listed Sponsors

lead

Janssen, LP

INDUSTRY